X
The LDN Book: How a Little-Known Generic Drug
The LDN Book: How a Little-Known Generic Drug

The LDN Book: How a Little-Known Generic Drug ― Low Dose Naltrexone ― Could Revolutionize Treatment for Autoimmune Diseases, Cancer, Autism, Depression, and More

Product ID : 8200257


Galleon Product ID 8200257
Shipping Weight 0.79 lbs
I think this is wrong?
Model
Manufacturer Chelsea Green Publishing
Shipping Dimension 8.9 x 5.98 x 1.3 inches
I think this is wrong?
-
Save 13%
Before ₱ 2,666
2,313

*Price and Stocks may change without prior notice
*Packaging of actual item may differ from photo shown
  • Electrical items MAY be 110 volts.
  • 7 Day Return Policy
  • All products are genuine and original
  • Cash On Delivery/Cash Upon Pickup Available

Pay with

The LDN Book: How a Little-Known Generic Drug Features

  • Ships from Vermont


About The LDN Book: How A Little-Known Generic Drug

Could a little-known drug really revolutionize treatment for autoimmune diseases, cancer, depression, and more? “[LDN] raises hopes of reversing memory loss in old age.”―the Guardian Over 30,000 copies sold! Low Dose Naltrexone (LDN) holds the potential to help millions of people suffering from various autoimmune diseases and cancers, and even autism, chronic fatigue, and depression, find relief. Administered off-label in small daily doses (0.5 to 4.5 mg), this generic drug is extremely affordable and presents few known side effects. So why has it languished in relative medical obscurity? The LDN Book explains: The drug’s origins Its primary mechanism The latest research from practicing physicians and pharmacists Compiled by Linda Elsegood of The LDN Research Trust―the world’s largest LDN charity organization with over 19,000 members worldwide―the book features ten chapters contributed by medical professionals on LDN’s efficacy and two patient-friendly appendices. The LDN Book is a comprehensive resource for doctors, pharmacists, and patients who want to learn more about how LDN is helping people now, and a clarion call for further research that could help millions more.